Shuwen Liu

Shuwen Liu's research centers on antiviral drug discovery, particularly targeting viruses such as influenza, SARS-CoV-2, HIV, HSV-2, and arenaviruses through small molecules and natural compounds. Work spans mechanistic virology (how viruses enter cells and evade immune responses), host-directed antiviral strategies, and immune signaling pathways like interferon and MAVS-mediated responses. The publication record also includes a wide range of unrelated topics, suggesting this name may aggregate output from multiple researchers or collaborative groups across diverse fields.

Publication output has remained steady to slightly growing over the last decade, rising from about 39 papers per year in 2017 to a peak of 61 in 2020, with recent years averaging around 40-50 publications annually.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026